Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Why is azopt so expensive?

See the DrugPatentWatch profile for azopt

Price Comparison and Exclusivity

Azopt (brinzolamide) is a prescription eye drop used to treat glaucoma and ocular hypertension, conditions characterized by increased intraocular pressure. Although it has been on the market since 1998, Azopt remains one of the more expensive options for treating glaucoma.

The price of Azopt has been influenced by patent protection and the lack of generic or biosimilar alternatives. According to DrugPatentWatch.com [1], the U.S. patent for Brinzolamide expired in 2015, but due to a series of extensions and settlements, the exclusive protection was not completely lost. This led to the delayed entry of generic competition.

Comparative Pricing and Market Dynamics

While several generic versions of Azopt were approved in the early 2020s [2][3], the prices did not significantly drop due to ongoing patent disputes. A recent market analysis indicates that a 5ml bottle of Azopt can cost anywhere from $50 to $100, with prices varying depending on the pharmacy, insurance coverage, and location [4].


Patient Assistance Programs and Options

Despite the high cost, patients may be able to access affordable versions of Azopt through various programs. The manufacturer, Alcon Pharmaceuticals, offers a patient assistance program that provides free or reduced-cost medication [5]. Other resources, such as non-profit organizations and independent charities, may also provide financial assistance for glaucoma patients.


Regulatory Environment and Future Developments

The U.S. FDA has approved several generic and biosimilar versions of Azopt in recent years. However, market exclusivity and patent disputes have contributed to the delayed entry of these alternatives. As patent protection for branded Azopt further erodes, it is likely that prices will decrease, and more affordable options will become available.


Key Sources:

[1] DrugPatentWatch.com. Brinzolamide patents. Retrieved 22 February 2023.
[2] FDA. Brinzolamide tablets. Retrieved 22 February 2023.
[3] FDA. Brinzolamide ophthalmic solution. Retrieved 22 February 2023.
[4] GoodRx. Brinzolamide Prices. Retrieved 22 February 2023.
[5] Alcon. Patient assistance programs. Retrieved 22 February 2023.



Other Questions About Azopt :

Bit azopt? Azopt eye drops price? Price of azopt eye drops? Azopt eye drops cost? Azopt price? Azopt? Azopt generic name?